Literature DB >> 3900241

CSF producing gall bladder cancer: case report and characteristics of the CSF produced by tumor cells.

M Takahashi, M Fujiwara, K Kishi, C Sakai, M Sanada, Y Moriyama, A Shibata.   

Abstract

Due to an increase in mature neutrophils, a 72-year-old female with gall bladder cancer showed leukocytosis of up to 1.32 X 10(11)/l; hypercalcemia was up to 7.7 mEq/l in her terminal stage. Leukocyte counts and calcium values increased as the tumor progressed. There was no sign of infection or bone marrow metastasis. Cultured cells from the tumor tissue produced high colony-stimulating factor (CSF) activity into the supernatant. The tumor cell-conditioned medium stimulated exclusively granulocytic colonies. The study of this patient shows that leukocytosis was caused by the CSF produced by tumor cells. Approximately 90% of CSF activity was lost by heat treatment at 60 degrees C for 30 min. The CSF was stable over a pH range of 3-11 and was inactivated by treatment with proteolytic enzymes, but was not affected by treatment with DNase or neuraminidase. Molecular weight of the CSF, demonstrated by fractionation using Sephacryl S-200, was approximately 27,000 to 30,000.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900241     DOI: 10.1002/stem.5530030502

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  9 in total

Review 1.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

2.  Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case.

Authors:  Tetsuo Ikeda; Kippei Ohgaki; Masatoku Miura; Shinichi Aishima; Toshihisa Shimizu; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 3.  Small cell gallbladder carcinoma complicated by paraneoplastic hyponatremia: a case report and literature review.

Authors:  Esther S Ng; Kotamma Venkateswaran; Shridhar I Ganpathi; Benjamin Y Chuah
Journal:  J Gastrointest Cancer       Date:  2010-12

4.  A case of gallbladder cancer producing granulocyte-colony-stimulating factor.

Authors:  T Takeda; A Ichiyanagi; K Sano; J Yoshida; Y Tsutsumi; T Miyaji
Journal:  Gastroenterol Jpn       Date:  1990-12

5.  Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: report of a case.

Authors:  Kazunori Shimada; Kazuhiro Iwase; Toyokazu Aono; Sumio Nakai; Shin-ichi Takeda; Makoto Fujii; Masaru Koma; Kazuhiro Nishikawa; Chu Matsuda; Masashi Hirota; Hiroaki Fushimi; Yasuhiro Tanaka
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

6.  An autopsy case of granulocyte-colony-stimulating-factor-producing extrahepatic bile duct carcinoma.

Authors:  Satoru Matsuyama; Tomonori Shimonishi; Hirofumi Yoshimura; Kensaku Higaki; Kenji Nasu; Mariko Toyooka; Shigehisa Aoki; Keiko Watanabe; Hajime Sugihara
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Granulocyte-colony stimulating factor-producing gallbladder carcinoma.

Authors:  Kazuhiro Suzumura; Yuji Iimuro; Yasukane Asano; Nobukazu Kuroda; Tadamichi Hirano; Junichi Yamanaka; Toshihiro Okada; Tomohiro Okamoto; Ikuko Torii; Jiro Fujimoto
Journal:  Int Surg       Date:  2014 Sep-Oct

8.  Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan.

Authors:  Tetsuo Tamura; Kazuo Takeuchi
Journal:  BMJ Case Rep       Date:  2013-06-11

9.  Granulocyte-colony stimulating factor-producing gallbladder carcinoma-include analysis all case reports: A case report.

Authors:  Wataru Izumo; Kenji Furukawa; Hideo Katsuragawa; Toru Tezuka; Tatsuya Furukawa; Kenichirou Hataji; Akio Komatsu; Kyousuke Shigematsu; Masakazu Yamamoto
Journal:  Int J Surg Case Rep       Date:  2016-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.